Differences in sociodemographic, clinical, psychosocial and health care characteristics between men and women diagnosed with fibromyalgia;Diferencias en características sociodemográficas, clínicas y psicológicas entre hombres y mujeres diagnosticados de fibromialgia

Revista Clinica Espanola

Volumn 207, Issue 9, 2007, Pages 433-439

  Ruiz Perez I ^a   Ubago Linares, M C ^a   Bermejo Perez M J ^a   Plazaola Castano J ^a   Olry De Labry Lima, A ^a   Hernandez Torres E ^a  

^a ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

Author keywords

Fibromyalgia; Gender identity; Sex characteristic

Indexed keywords

4 AMINOBUTYRIC ACID; ANTIINFLAMMATORY AGENT; MUSCLE RELAXANT AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FIBROMYALGIA; HEALTH CARE SYSTEM; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LEAVE; PSYCHOSOCIAL CARE; SOCIOECONOMICS; UNIVERSITY HOSPITAL; WORK ENVIRONMENT;

EID: 35348847187     PISSN: 00142565     EISSN: 15781860     Source Type: Journal    
DOI: 10.1157/13109832     Document Type: Article

References (30)

1. Ostlin P. Gender in health research - past, present and future. En Matlin S. Global forum update on research for health, Vol. 2. Londres: Pro Brook Publishing; 2005. p. 60-3.
2. Griffiths S. Men's health: unhealthy lifestyles and an unwillingness to seek medical healp. British Medical Journal. 1996;312:69-70.
3. Ruiz MT, Verdu M. Gender bias in treatment. Gaceta Sanitaria. 2006;18 Suppl 1):118-25.
4. Chandola T, Kuper H, Singh A, Bartley M, Marmot M. The effect of control at home on CHD events in the Whitehal II study: Gender differences in psychosocial domestic pathways to social inequalities in CHD. Social Science and Medicine. 2004;58(8):1501-9.
5. Consensus Document on Fibromyalgia. The Copenhagen Declaration (1993). Journal of Musculosketal pain. Vol. 1. New York: Haworth Press; 1993.
6. García A. Fibromialgia. Revista Española de Reumatología. 2000;27:447-9.
7. Valverde M. Prevalencia de la fibromialgia en la población española. Estudio EPISER (resumen). Revista Española de Reumatología. 2000;27:157.
8. Valverde M, Juan A, Rivas B, Carmona L. Fibromialgia. En: Estudio EPISER. Prevalencia e impacto de las enfermedades reumáticas en la población adulta española. Madrid: Msd y Sociedad Española de Reumatología; 2001. p. 77-91.
9. Campos Sánchez S. Fibromialgia. Rev. Esp Reumatol. 2000;27:417-20.
10. González M, Tornero J, Carbonell J, Gabriel R, Sánchez-Magro I. Calidad de vida y depresión en el estudio EPIDOR. Revista Española de Reumatología. 2005;32(2):52-9.
11. Mulero Mendoza J. Fibromialgia. Medicine. 1997;7:2682-7.
12. Bosch Romero E, Sáenz Moya N, Valls Esteve M, Viñolas Valer S. Estudio de la calidad de vida en pacientes con fibromialgia: impacto de un programa de educación sanitaria. Aten Primaria. 2002;30(1):16-21.
13. Wolfe F, Smythe HA, Yunnus MB, Bennet RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Artritis Rhem. 1990;33:160-72.
14. Hazemeijer I, Rasker JJ. Fibromialgia and the therapeutic domain. A philosophical study on the origins of fibromialgia in a specific social setting. Rheumatology (Oxford). 2003;42:507-15.
15. Albornoz J, Povedano J, Quijada J, de la Iglesia JL, Fernández A, Pérez-Vilchez D, et al. Características clínicas y sociolaborales de la fibromialgia en España: descripción de 193 pacientes. Rev Esp Reumatol. 1997;24:38-44.
16. Mease P. Fibromyalgia syndrome: review of clinical presentation, pathogenesis, outcome measures and treatment. J Rheumatol, Suppl 2005;32:2063.
17. Andreu JL, Sanz J. Fibromyalgia and its diagnosis. Rev Clin Esp. 2005;205(7):333-6.
18. White K, Speechley M, Hart M, Ostbye T. Comparing Self-Reported function and work disability in 100 community cases of fibromyalgia syndrome versus controls in London, Ontario. The London FMS Epidemiology Study. Arthritis Rheum. 1999;42:76-83.
19. Tuzun EH, Albayrak G, Eker L, Sozay S, Daskapan A. A comparison study of quality of life in women with fibromyalgia and myofascial pain syndrome. Disabil Rehabil. 2004;18:198-202.
20. Wolfe F, Michaud K. Severe rheumatoid arthritis (RA), worse outcomes, comorbidity illness, and sociodemographic disadvantage characterize patients with fibromyalgia. J Rheumatol. 2004;31:696-700.
21. Wolfe F, Ross K, Anderson J, Russell IJ. Aspects of fibromyalgia in the general population: sex, pain threshold, and fibromyalgia symptoms. J Rheumatol. 1995; 22:151-6.
22. Yunus MB, Inanici F, Aldag JC, Mangold RF. Fibromyalgia in men: comparasion of clinical features whith women. J Rheumatol. 2000;27:485-90.
23. Buskila D, Neumann L, Aloashle A, Abu-Shakra M. Fibromyalgia syndrome in men. Semin Arthritis Rheum. 2000;30:47-51.
24. Yunus MB. Gender differences in fibromialgia and other related syndromes. Journal of Gender Specific Medicine. 2002;5(2):42-7.
25. Rivera J, González T. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol. 2004;22(5):554-60.
26. Simpson CR, Hannaford PC, Williams D. Evidence for inequalities in the management of coronary heart disease in Scotland. Heart. 2005;91(5):630-4.
27. Larrañaga N, Baterretxea M. Infarto agudo de miocardio con ingreso hospitalario en Guipúzcoa. Gaceta Sanitaria. 2002;16 Supl 1:60.
28. Yunus MB, Celiker R, Aldag JC. Fibromyalgia in men: comparison of psychological features with women. J Rheumatol. 2004;31(12):2464-7.
29. Desjarlais R, Eisenberg L, Good B, Kleinman A. World Mental Health. London: Oxford; 1995.
30. O'Malley PG, Balden E, Tomkins G, Santoro J, Kroenche K, Jackson JL. Treatment of fibromialgia with antidepressants: a meta-analysis. Journal of General Internal Medicine. 2000;15(9):659-66.